These guidelines provide a practical and evidence-based resource for the management of
patients with Barrett's oesophagus and related early neoplasia. The Appraisal of Guidelines …

Incidence of oesophageal adenocarcinoma has increased exponentially in the West over
the past few decades. Following detection of advanced cancers, 5-year survival rates remain …

BACKGROUND & AIMS: Esophageal adenocarcinoma (EA) is increasingly common among
patients with Barrett's esophagus (BE). We aimed to provide consensus recommendations …

Objective After focal endoscopic resection (ER) of high-grade dysplasia (HGD) or early
cancer (EC) in Barrett's oesophagus (BO), eradication of all remaining BO reduces the …

BACKGROUND & AIMS: Radiofrequency ablation (RFA) is safe and effective for eradicating
intestinal metaplasia and neoplasia in patients with Barrett's esophagus. We sought to …

The endoscopic caps often bridge the can to the could. It is among the best inventions in
endoscopy. The cap adds practical functionality to the endoscope–some of which cannot be …

Background and Aims Endoscopic resection (ER) is safe and effective for Barrett's
esophagus (BE) containing high-grade dysplasia (HGD) or mucosal adenocarcinoma (T1A) …

Objective Due to an annual progression rate of Barrett's oesophagus (BO) with low-grade
dysplasia (LGD) between 9% and 13% per year endoscopic ablation therapy is preferred to …

BACKGROUND & AIMS: Radiofrequency ablation (RFA) is safe and effective treatment for
flat dysplasia associated with Barrett's esophagus (BE). However, there are limited data on …

The frequency of endoscopic complications is likely to rise owing to the increased number of
indications for therapeutic procedures and also to the increased complexity of endoscopic …